Transparency Market Research has published a research report that discusses the complex trends and dynamics prevalent in the global cardiac prosthetic devices market. The research report, titled “Cardiac Prosthetic Devices Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” presents a thorough analysis of the market drivers and restraints acting on the global cardiac prosthetics market. In addition to this, the research report also evaluates the key elements influencing the operational functionalities in the global cardiac prosthetic devices market.
Download Brochure For More Information About Devices: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1721
According to the research report, the global cardiac prosthetic devices market was valued at US$2.9 bn in 2012 and is expected to reach US$5.3 bn by 2019, rising at a CAGR of 8.7% between 2013 and 2019. The growth of the global cardiac prosthetic devices market will be attributable to the growing cases of cardiovascular diseases across the globe.
Cardiac prosthetics are the best possible option for replacing a dysfunctional or diseased part of the heart. These medical devices are used for treating heart valves blockages. Today, implanting a cardiac prosthetic device is a common procedure for patients suffering from cardiovascular diseases. Some of the complications related to the failure of primary valves are prosthetic valve thrombosis (PVT), mechanical hemolytic anemia, prosthetic valve endocarditis (PVE), and thromboembolism.
The global cardiac prosthetic devices market is segmented on the basis of heart valve, pacemaker, and geography. The types of heart valves available in the global cardiac prosthetic devices market are mechanical heart valves, transcatheter heart valves, and tissue heart valves. The types of pacemakers in the market are implantable pacemakers and external pacemakers. Geographically, this market is segmented into North America, Europe, Asia Pacific, and Rest of the World.
Out of all regional segment of the global cardiac prosthetic devices market, North America held a 35% share in the overall market in 2012. This region is expected to continue its dominance all through the forecast period due to a good presence of high-end technology, state-of-the-art infrastructure and medical facilities, and skilled healthcare personnel. Furthermore, the growing cardiac cases and conducive healthcare reimbursement policies are also propelling the global cardiac prosthetic devices market.
Analysts predict that Asia pacific will be the next big market for cardiac prosthetic devices due to growing support from the governments in the regions and improving healthcare facilities. Additionally, the increasing disposable incomes of the overall population and the technological advancements in medical devices and solutions are also expected to drive the cardiac prosthetic market in Asia Pacific.
Some of the important players in the global molecular diagnostics market are Roche Diagnostics, Abbott Laboratories, Cepheid, and Becton Dickinson & Company. The research report offers a detailed explanation of the competitive landscape of the global molecular diagnostic market and states the influence of the regulatory framework governing it. Furthermore, the research report also evaluates the financial overview, research and development strategies, strategic mergers and acquisitions, and product portfolio of these top players.
The global cardiac prosthetic devices market is segmented as:
Cardiac Prosthetic Devices Market, by Product
Mechanical Heart Valves
Tissue Heart Valves
Stented Tissue Valve
Stentless Tissue Valve
Transcatheter Heart Valves
Single-Chamber Battery Pacemaker
Dual-Chamber Battery Pacemaker
Triple-Chamber Battery Pacemaker
Browse Full Report With TOC: http://www.transparencymarketresearch.com/cardiac-prosthetic-market.html